A Novel Targeted Therapy System for Cervical Cancer:  Co-Delivery System  of  Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier

BACKGROUND: This study was aimed to prepare a novel magnetic thermosensitive cationic liposome drug carrier for the codelivery of Oxaliplatin (OXA) and antisense lncRNA of MDC1 (MDC1-AS) to Cervical cancer cells and evaluate the efficiency of this drug carrier and its antitumor effects on Cervical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Hui, Chu, Xiaoying, Cao, Zhensheng, Hu, Xuanxuan, Wang, Zihan, Li, Meiqi, Wan, Leyu, Li, Yongping, Cao, Yongge, Diao, Zhanqiu, Peng, Fengting, Liu, Jinsong, Xu, Lihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886386/
https://www.ncbi.nlm.nih.gov/pubmed/33603368
http://dx.doi.org/10.2147/IJN.S258316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886386/
https://www.ncbi.nlm.nih.gov/pubmed/33603368
http://dx.doi.org/10.2147/IJN.S258316

Ejemplares similares